Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 3
2007 2
2008 1
2009 1
2010 3
2011 3
2012 3
2013 6
2014 3
2015 5
2016 1
2017 3
2018 1
2021 4
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines.
Kenigsberg TA, Goddard K, Hanson KE, Lewis N, Klein N, Irving SA, Naleway AL, Crane B, Kauffman TL, Xu S, Daley MF, Hurley LP, Kaiser R, Jackson LA, Jazwa A, Weintraub ES. Kenigsberg TA, et al. Among authors: jazwa a. Vaccine. 2023 Sep 7;41(39):5678-5682. doi: 10.1016/j.vaccine.2023.08.023. Epub 2023 Aug 19. Vaccine. 2023. PMID: 37599140
Limb ischemia and vessel regeneration: Is there a role for VEGF?
Jazwa A, Florczyk U, Grochot-Przeczek A, Krist B, Loboda A, Jozkowicz A, Dulak J. Jazwa A, et al. Vascul Pharmacol. 2016 Nov;86:18-30. doi: 10.1016/j.vph.2016.09.003. Epub 2016 Sep 10. Vascul Pharmacol. 2016. PMID: 27620809 Review.
Critical View on Mesenchymal Stromal Cells in Regenerative Medicine.
Langrzyk A, Nowak WN, Stępniewski J, Jaźwa A, Florczyk-Soluch U, Józkowicz A, Dulak J. Langrzyk A, et al. Among authors: jazwa a. Antioxid Redox Signal. 2018 Jul 10;29(2):169-190. doi: 10.1089/ars.2017.7159. Epub 2017 Oct 11. Antioxid Redox Signal. 2018. PMID: 28874054 Review.
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
Gubernot D, Jazwa A, Niu M, Baumblatt J, Gee J, Moro P, Duffy J, Harrington T, McNeil MM, Broder K, Su J, Kamidani S, Olson CK, Panagiotakopoulos L, Shimabukuro T, Forshee R, Anderson S, Bennett S. Gubernot D, et al. Among authors: jazwa a. Vaccine. 2021 Jun 23;39(28):3666-3677. doi: 10.1016/j.vaccine.2021.05.016. Epub 2021 May 14. Vaccine. 2021. PMID: 34088506 Free PMC article. Review.
40 results